GENE ONLINE|News &
Opinion
Blog

CRISPR Therapeutics
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
Canadian Regulators Give Go-Ahead for Diabetes Trial Using CRISPR, ViaCyte’s Gene-Edited Stem Cell-Derived Therapy
2021-11-16
Setting its Sights on Neurological Disorders, CRISPR Therapeutics Turns to an AAV Startup That Just Emerged Out of Stealth
2021-06-16
Vertex to Reap Majority Profits from Gene Editing Deal with CRISPR Therapeutics
2021-04-21
10 Top Gene Therapy Companies in 2021
2021-03-26
CRISPR Therapeutics Scores Prestigious Grant for Advancing Gene Therapies for HIV
2020-12-16
CRISPR Gene-Edited Therapy CTX001 Raises Hopes for Sickle Cell Disease and β-Thalassemia Cures
2020-12-07
CRISPR Therapeutics’ CAR-T Cell Therapy Registers Mixed Results in Cancer Trial
2020-10-23
CRISPR, Vertex’s Gene Editing Based Therapy, CTX001 Prospers in Hemoglobinopathy Trials
2020-06-18
GeneOnline’s Top Ten Headlines of the Year
2019-12-30
R&D
Gene Editing Companies to Exchange Patented Tech to Develop Cancer Therapies
2019-10-28
LATEST
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
Singapore’s NUS Medicine Launches Centre for Sustainable Medicine
2023-11-20
Pioneering Partnership: Africa CDC and China CDC Elevate Public Health Initiatives
2023-11-20
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
Scroll to Top